Improving medical care for patients with HIV in New York City jails

Journal of Correctional Health Care : the Official Journal of the National Commission on Correctional Health Care
Mohammed JafferHomer Venters

Abstract

Correctional institutions play an important role in identifying HIV-positive patients and initiating and continuing their care. However, the actual medical care provided to patients with HIV in jail is poorly characterized. The New York City jail system cares for approximately 7,500 HIV-positive persons each year, including approximately 125 who are newly identified during testing in jail. Analysis of patient data reveals that only 17% of newly identified HIV-positive patients were started on therapy, with the most common reasons for not initiating being not meeting clinical guidelines or short stay. Among known HIV-positive patients, rates of medication continuation were high. Keys to success in maintaining a high level of care for HIV-positive patients include real-time evaluation of the population, routine feedback to providers, and case conferencing.

References

Jul 1, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sandra A SpringerFrederick L Altice
Apr 3, 2008·American Journal of Public Health·Emily A WangJacqueline P Tulsky
Aug 10, 2010·Journal of Health Care for the Poor and Underserved·David Wyatt SealJames Sosman
Oct 1, 2010·Journal of Correctional Health Care : the Official Journal of the National Commission on Correctional Health Care·Charulata J SabharwalFarah Parvez
Oct 19, 2010·HIV Therapy·Sarah E Wakeman, Josiah D Rich

❮ Previous
Next ❯

Citations

Feb 16, 2013·American Journal of Public Health·Joan BrittainHomer Venters
Mar 13, 2014·AIDS Patient Care and STDs·Curt BeckwithJosiah Rich
Dec 10, 2020·International Journal of STD & AIDS·Putu DuffKathleen Deering

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.